Endoscopy adverse events (AEs), or complications, are a rising concern on the quality of endoscopic care, given the technical advances and the crescent complexity of therapeutic procedures, over the entire gastrointestinal and bilio-prancreatic tract. In a small percentage, not established, there can be real emergency conditions, as perforation, severe bleeding, embolization or infection. Distinct variables interfere in its occurrence, although, the awareness of the operator for their potential, early recognition, and local organized facilities for immediate handling, makes all the difference in the subsequent outcome. This review outlines general AEs’ frequencies, important predisposing factors and putative prophylactic measures for specif...
The Summary of Recommendations1 ESGE recommends that each center implements a written policy regardi...
Background / study aims : The objective of this study is to identify and describe risk factors and c...
The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival...
Endoscopy adverse events (AEs), or complications, are a rising concern on the quality of endoscopic ...
AbstractBleeding is a common adverse event following invasive endoscopic procedures within the gastr...
The frequency of endoscopic complications is likely to rise owing to the increased number of indicat...
The balance between risks and benefits of gastrointestinal endoscopy for a given patient is essentia...
Background/Aims: Gastrointestinal perforation during endoscopy is a rare but severe complication. Mo...
Background and study aims Medical error occurs frequently with significant morbidity and mortality. ...
A clear understanding of the potential complications or adverse events (AEs) of diagnostic endoscopy...
BACKGROUND AND STUDY AIMS: Gastrointestinal endoscopic procedures have evolved significantly in the ...
Background: The management of patients who develop gastrointestinal (GI) bleeding after acute myocar...
This Position Paper is an official statement of the European Society of Gastrointestinal Endoscopy (...
Gastrointestinal endoscopy plays an essential role in the diagnosis, staging, and treatment of patho...
This Position Paper is an official statement of the European Society of Gastrointestinal Endoscopy (...
The Summary of Recommendations1 ESGE recommends that each center implements a written policy regardi...
Background / study aims : The objective of this study is to identify and describe risk factors and c...
The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival...
Endoscopy adverse events (AEs), or complications, are a rising concern on the quality of endoscopic ...
AbstractBleeding is a common adverse event following invasive endoscopic procedures within the gastr...
The frequency of endoscopic complications is likely to rise owing to the increased number of indicat...
The balance between risks and benefits of gastrointestinal endoscopy for a given patient is essentia...
Background/Aims: Gastrointestinal perforation during endoscopy is a rare but severe complication. Mo...
Background and study aims Medical error occurs frequently with significant morbidity and mortality. ...
A clear understanding of the potential complications or adverse events (AEs) of diagnostic endoscopy...
BACKGROUND AND STUDY AIMS: Gastrointestinal endoscopic procedures have evolved significantly in the ...
Background: The management of patients who develop gastrointestinal (GI) bleeding after acute myocar...
This Position Paper is an official statement of the European Society of Gastrointestinal Endoscopy (...
Gastrointestinal endoscopy plays an essential role in the diagnosis, staging, and treatment of patho...
This Position Paper is an official statement of the European Society of Gastrointestinal Endoscopy (...
The Summary of Recommendations1 ESGE recommends that each center implements a written policy regardi...
Background / study aims : The objective of this study is to identify and describe risk factors and c...
The use of antiangiogenic agents (AAs) in cancer treatment has increased because they offer survival...